We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.
- Authors
Ettinger, B; Black, D M; Mitlak, B H; Knickerbocker, R K; Nickelsen, T; Genant, H K; Christiansen, C; Delmas, P D; Zanchetta, J R; Stakkestad, J; Glüer, C C; Krueger, K; Cohen, F J; Eckert, S; Ensrud, K E; Avioli, L V; Lips, P; Cummings, S R
- Abstract
Raloxifene hydrochloride, a selective estrogen receptor modulator, prevents bone loss in postmenopausal women, but whether it reduces fracture risk in these women is not known.
- Publication
JAMA, 1999, Vol 282, Issue 7, p637
- ISSN
0098-7484
- Publication type
Journal Article
- DOI
10.1001/jama.282.7.637